Our data could serve as a basis for future studies leading to the design of new therapeutic options, e.g. the generation and/or optimization of novel sequence-tailored TLR7/8 agonists and/or antagonists, and further targeted immunomodulation-based therapies for COVID-19 patients (69, 71, 72). Here, TLR7 is linked to COVID-19.